Our approach to cancer research is unique. Using world-leading modelling and analysis, our research informs short-, medium- and long-term action in cancer control. We are committed to finding the most effective ways for reducing cancer death and illness across all interventions – prevention, early detection, treatment and care. Our existing focus areas include cervical and HPV, prostate, lung, breast, ovarian, gastrointestinal (bowel and liver) cancers, and melanoma, as well as hereditary cancers related to Lynch Syndrome.
Our research is underpinned by our own innovative predicative modelling platform, Policy-1, which allows us to ask a series ‘what if’ questions to identify the best ways to reduce the impact of cancer – from prevention, to early detection and screening strategies, treatment and survivorship. Integrated with epidemiological research, analysis of large-scale health datasets, economic evaluation, systematic and evidence reviews, with a strong implementation, evaluation and translational focus, this approach enables us to provide expert, independent evidence to inform policy and clinical practice both nationally and internationally.
Our research also directly informs Cancer Council activities across cancer prevention, advocacy, information and support, guiding our programs and priorities, guiding our work towards our mission of a cancer free future.
